Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Axfood AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 50.44B | 21.3x | 2.6 | SEK 236.20 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.2% Upside | Upgrade to Pro+ | |
Viva Wine AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 3.48B | 30.9x | -1.27 | SEK 38.50 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.5% Upside | Upgrade to Pro+ | |
EQL Pharma | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 2.44B | 78.5x | 4.78 | SEK 84 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.6% Downside | Upgrade to Pro+ | |
AcuCort | Spotlight | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 91.28M | -4.5x | -0.1 | SEK 0.63 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Newbury Pharmaceuticals AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 85.39M | -4.8x | -0.2 | SEK 3.54 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Harm Reduction AB | Spotlight | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 18.63M | -0.4x | 0 | SEK 0.05 | 61.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |